Literature DB >> 11460721

Flounder health status in the Seine Bay. A multibiomarker study.

C Minier1, F Levy, D Rabel, G Bocquené, D Godefroy, T Burgeot, F Leboulenger.   

Abstract

The Seine Bay is used as a pilot area to assess the usefulness of monitoring programmes using a suite of biological measurements. These biomarkers included ethoxyresorfin-O-deethylase (EROD) and acetylcholinesterase (AChE) activities, multixenobiotic resistance (MXR) protein expression level assessment and gonad histopathology. Samples of European flounder collected in three sites close to the Seine Estuary in late September 1998 showed that 8% of the males were intersex, i.e. had gonads with both male and female tissues. Another 10% of individuals, identified as male by morphological observation during sampling, showed only female tissues on histological sections. These dramatic changes were associated with different patterns of EROD activity, MXR expression or AChE activity inhibition that might reflect shorter time effects of xenobiotics and constitute a starting point to integrate biological responses for the assessment of the health status of flounder in the Seine Bay.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11460721     DOI: 10.1016/s0141-1136(00)00059-3

Source DB:  PubMed          Journal:  Mar Environ Res        ISSN: 0141-1136            Impact factor:   3.130


  2 in total

1.  Effects of malathion and cadmium on acetylcholinesterase activity and metallothionein levels in the fish Seriola dumerilli.

Authors:  J Jebali; M Banni; H Guerbej; E A Almeida; A Bannaoui; H Boussetta
Journal:  Fish Physiol Biochem       Date:  2006-03       Impact factor: 2.794

2.  Relationship between sex steroid and vitellogenin concentrations in flounder (Platichthys flesus) sampled from an estuary contaminated with estrogenic endocrine-disrupting compounds.

Authors:  Alexander P Scott; Ioanna Katsiadaki; Mark F Kirby; John Thain
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.